Skip to Content
Merck
  • Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1.

Protective effects of polydatin on septic lung injury in mice via upregulation of HO-1.

Mediators of inflammation (2013-02-23)
Xiao-hui Li, Xia Gong, Li Zhang, Rong Jiang, Hong-zhong Li, Meng-jiao Wu, Jing-yuan Wan
ABSTRACT

The present study was carried out to investigate the effects and mechanisms of polydatin (PD) in septic mice. The model of cecal ligation and puncture (CLP-)induced sepsis was employed. Pretreatment of mice with PD (15, 45, and 100 mg/kg) dose-dependently reduced sepsis-induced mortality and lung injury, as indicated by alleviated lung pathological changes and infiltration of proteins and leukocytes. In addition, PD inhibited CLP-induced serum tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) production, lung cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase isoform (iNOS) protein expressions and NF-κB activation. Notably, PD upregulated the expression and activity of heme oxygenase (HO-)1 in lung tissue of septic mice. Further, the protective effects of PD on sepsis were abrogated by ZnPP IX, a specific HO-1 inhibitor. These findings indicated that PD might be an effective antisepsis drug.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
3,4′-5-Trihydroxystilbene-3-β-D-glucopyranoside, 97%
Sigma-Aldrich
Polydatin, ≥95% (HPLC)